Barinthus Biotherapeutics plc (BRNS) Misses Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts BRNS Hot Sheet
Join SI Premium – FREE
Barinthus Biotherapeutics plc (NASDAQ: BRNS) reported Q2 EPS of ($0.43), $0.03 worse than the analyst estimate of ($0.40).
For earnings history and earnings-related data on Barinthus Biotherapeutics plc (BRNS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VNET Group (VNET) Misses Q2 EPS by 164c
- Carvana's share gains and production growth remain on track, Wells Fargo says
- Mizuho Reiterates Outperform Rating on Uber Inc. (UBER)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
